EIF3M and hepatocellular carcinoma: The experimental results demonstrated that EIF3M overexpression significantly enhanced the proliferative capacity of hepatocellular carcinoma cells, while EIF3M knockdown resulted in a marked reduction in tumor cell proliferation (Figure 7B).